About Us

Darren Bounds
CEO & Co-Founder

As someone having the lifelong autoimmune disease, ulcerative colitis, Darren was inspired to co-found Trusted Therapies to give fellow patients access to international experts so that patients can get detailed, accurate information about their diseases and the therapies available.

A 10-year career in the pharmaceutical industry enabled him to work with international experts on educational programs for other doctors. It was at these programs on Crohn’s and ulcerative colitis that Darren saw the wealth of information that expert doctors had access to. He wished his fellow patients could also have the privilege of tapping into the minds of the experts.

His wish came true when he partnered with international expert Dr. Brian Bressler and left his career in the pharmaceutical industry to start Trusted Therapies.

Darren studied molecular biology and biochemistry at Simon Fraser University.

Dr. Brian Bressler
Chief Medical Officer & Co-Founder

Dr. Bressler is an ambitious doctor that has risen to the rank of international expert on Inflammatory Bowel Disease (IBD). Following advanced training at Harvard Medical School, he has been very active in both inflammatory bowel disease research and in educating and treating his patients. He is also kept busy by speaking at educational programs for fellow gastroenterologists and by speaking at patient education events.

He is passionate about Trusted Therapies because it will enable expert doctors to share their knowledge with a much larger audience of patients with IBD.

Dr. Bressler is the Director of the Advanced IBD training program at the University of British Columbia. He is also a member of the GI Research Institute in Vancouver, one of the most active gastroenterology research centres in North America.

Editorial Independence

Trusted Therapies has full control over the content on the site. We are very grateful to have received sponsorship from the following companies, who did so with the understanding that they have no influence on the content we create for the site.